| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | CK1441RCZ8 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Insulin-like growth factor I receptor antagonist | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Sarcoma, Ewing | 2 | D012512 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Hemangiosarcoma | 2 | D006394 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Rhabdomyosarcoma | 1 | D012208 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Small Cell Lung Carcinoma | 1 | D055752 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
| Sarcoma | 0 | D012509 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 905703-97-1 |
| ChEMBL | CHEMBL1743024 |
| FDA SRS | CK1441RCZ8 |
CONTENTS